Neue Suche | Kongressdetail
mail
Druckansicht
 
 

3rd In Vivo Cell Engineering and Gene Editing Summit

Evvnt Promotion / evvnt
-
09.07.2024 - 11.07.2024  The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 4:10 PM
 
Kongressthemen
Welcome to the 3rd In Vivo Cell Engineering and Gene Editing Summit!

As promising pre-clinical and proof of concept results continue to emerge, the pivotal shift from the 'dream' of in vivo cell engineering and gene editing is rapidly becoming a reality as numerous companies push towards the clinic.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2291382-3?pid=4832

Speakers: Adrian Bot, Chief Scientific Officer, Capstan Therapeutics, Cecile Bauche, Chief Scientific Officer, Alaya.bio, Colin Exline, Head of Gene Editing, Primera Therapeutics, and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/2291382-2?pid=4832
Frau Kelly Cassidy
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 2599.00 - USD 5097.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHelix - Forschung & Beratung WiennewTreeHilfswerk AustriaEuropean Public Health Association (EUPHA)Österreichische Akademie der ÄrzteSwiss Tropical and Public Health InstituteAMREF - African Medical and Research Foundation